Onco Wiki / drapeau rouge

Active or latent infection requiring resolution / prophylaxis before initiating cisplatin...

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

IDRF-HNSCC-INFECTION-SCREENING
TypeSignal d’alerte
Étatreviewed 2026-04-27 | pending_clinical_signoff
MaladiesDIS-HNSCC
SourcesSRC-ESMO-HNSCC-2020 SRC-NCCN-HNSCC-2025

Origine du drapeau rouge

DéfinitionActive or latent infection requiring resolution / prophylaxis before initiating cisplatin-based chemoradiation, cetuximab + RT, or pembrolizumab in HNSCC: HBsAg-positive (HBV reactivation on cytotoxic chemotherapy + checkpoint inhibitors), anti-HBc-positive (occult HBV on cetuximab — anti-EGFR class), HIV-positive (ART coordination, often comorbid in HPV-related HNSCC), or active TB.
Direction cliniqueen attente
Catégoriedépistage des infections

Logique de déclenchement

{
  "any_of": [
    {
      "finding": "hbsag",
      "value": "positive"
    },
    {
      "finding": "anti_hbc_total",
      "value": "positive"
    },
    {
      "finding": "hiv_status",
      "value": "positive"
    },
    {
      "finding": "active_tb",
      "value": true
    }
  ],
  "type": "lab_value"
}

Notes

Cetuximab — anti-EGFR mAb — has documented HBV reactivation reports (less than rituximab but non-zero); FDA label notes warning. Standard HBsAg + anti-HBc + anti-HBs serology pre-treatment; entecavir / tenofovir for HBsAg+. HIV-related HNSCC (oropharyngeal, cervical squamous) is increasingly recognized; ART coordination critical before cisplatin (renal interactions with tenofovir DF) — switch to TAF or coordinate with infectious disease. Active TB: complete anti-TB before head-and-neck RT given mucositis + neutropenia overlap.

Utilisé par

Indication